{"database": "lobbying", "table": "lobbying_activities", "rows": [[2262069, "b8e7935f-1e37-4ba0-aa2d-7a8d7ce0c2fc", "Q1", "RED+BLUE STRATEGIES", 400693064, "CAMBIA HEALTH SOLUTIONS (FORMERLY KNOWN AS THE REGENCE GROUP)", 2019, "first_quarter", "MMM", "Trump Administration regulations regarding prescription medications in the Medicare and Medicaid programs.", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2019-04-05T12:03:44.447000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2262069"], "units": {}, "query_ms": 0.6553279818035662, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}